BIO-B
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$381.37
+4.46%Forward multiples
Based on analyst estimates
- P/E forward
- 35.42x
- P/E 2026E
- 37.65x
- P/E 2027E
- 34.57x
- P/E 2028E
- 31.18x
- P/S forward
- 3.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- 45.78x
- PEG TTM
- 1.50x
- Price / book
- 1.42x
- Price / sales
- 3.94x
- Price / cash flow
- 20.70x
Enterprise value
- Enterprise value
- $9.8B
- EV / sales
- 3.78x
- EV / EBITDA
- 18.30x
- EV / EBIT
- 41.63x
- Market cap
- $10.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026